Introduction {#Sec1}
============

Natural products are a big treasure for human beings, which exhibit rich academic and industrial potentials due to their structural diversity and biological activities. As we know, γ-butyrolactones with common structures of γ-(*E*)-vinylic and alkylic γ-butyrolactones, *E-***I**^[@CR1]--[@CR4]^ and **II**^[@CR5]--[@CR10]^, exist extensively in nature and many of them have been identified with interesting biological potentials, such as anti-HIV^[@CR1]^, anti-fungal^[@CR2],[@CR9]^, cytotoxic^[@CR3]^, anti-bacterial^[@CR7]^, anti-proliferative^[@CR8]^ activities, etc., featuring applications in pharmacy (Fig. [1](#Fig1){ref-type="fig"}). Some of these lactones, especially for aliphatic γ-butyrolactones, are also common flavor source in plants and food, which involved in several metabolic pathways^[@CR11]^.Fig. 1Representative examples of γ-(*E*)-vinylic and γ-alkylic-γ-butyrolactones. **a** Common structure unit and representative examples of γ-(*E*)-vinylic γ-butyrolactones (*E-***I**); **b** Common structure unit and representative examples of γ-alkylic γ-butyrolactones (**II**)

So far, very few highly selective asymmetric synthesis of *E-***I**-type γ-butyrolactones with a *trans* 1,3-disubstituted C=C bond has been reported^[@CR12],[@CR13]^. The approaches for the synthesis of unique γ-(2,2-disubstituted or 1-iodo) vinylic γ-butyrolactones^[@CR14]--[@CR18]^ are not applicable for the synthesis of the natural γ-butyrolactones due to the substrate limitation. It is well reasoned that in the Au-catalyzed enantioseletcive approach the control of *E*/*Z* selectivity and enantioselectivity are most likely the challenge when 6-mono-substituted allenoic acids were used (Fig. [2d](#Fig2){ref-type="fig"})^[@CR14]--[@CR16]^. We envisioned a Au-catalyzed cycloisomerization^[@CR19]--[@CR25]^ of optically active 4,5-alkadienoic acids, readily available from terminal alkynes and aldehydes, for the direct access to various natural and non-natural enantioenriched *E-***I**-type common γ-butyrolactones, which could further be easily hydrogenated to provide naturally occurring γ-alkylic γ-butyrolactones **II** (Fig. [2e](#Fig2){ref-type="fig"}). The latter was usually prepared via the lactonization (Fig. [2a](#Fig2){ref-type="fig"})^[@CR26]--[@CR29]^, Baeyer-Villiger oxidation (Fig. [2b](#Fig2){ref-type="fig"})^[@CR30]^, and dihydroxylation-lactonization-elimination (Fig. [2c](#Fig2){ref-type="fig"}), etc^[@CR31]--[@CR34]^. The challenge for strategy in Fig. [2e](#Fig2){ref-type="fig"} is the efficiency of axial-to-central chirality transfer^[@CR35]--[@CR43]^ and the control of *Z*/*E* selectivity (*E*-**I** vs. *Z*-**I**, which after hydrogenation would afford the enantiomers of lactones **II**, respectively, thus, leading to a much lower ee) during the cyclic anti-nucleometalation and the efficiency of the proto demetalation process to deliver the required 1,3-disubstituted *E*-C=C bond finishing the catalytic cycle. Overall it is highly desirable to identify a suitable ligand **L** for a much more stable complex **I** over complex **II**.Fig. 2Known approaches and the designed general protocol to γ-butyrolactones *E*-**I** and **II**. **a** Nature's enzymatic approaches; **b** Baeyer--Villiger oxidation; **c** Alkenoate dihydroxylation; **d** Allene enantioselective approach described in refs. ^[@CR14]--[@CR16]^. **e** Au-catalyzed chirality transfer-based asymmetric cyclization of allenoic acids (this work)

Herein, we present the highly stereoselective cycloisomerization of optically active 5-monosubstituted 4,5-alkadienoic acids affording various non-natural and natural enantioenriched γ-(*E*)-alkenyl-γ-butyrolactones by using AuCl(LB-Phos) as the catalyst.

Results {#Sec2}
=======

Synthesis of AuCl(LB-Phos) {#Sec3}
--------------------------

At the beginning, we treated (*R*~a~)-4,5-tridecadienoic acid (*R*~a~)-**5a** (for its synthesis from aldehyde and terminal alkyne, see: Supplementary Tables [1](#MOESM1){ref-type="media"} and [2](#MOESM1){ref-type="media"}) as the model substrate. After screening of some commonly used gold catalysts such as AuCl, AuCl(IPr), Au~2~Cl~2~(dppm), Au~2~Cl~2~(dppm) combined with AgOTs was identified as the first generation catalyst to afford the desired γ-1*(E)*-*alkenyl* (*S*)-γ-butyrolactone (*S*,*E*)-**6a** in a quantitative yield with a *E*/*Z* selectivity of 93:7 and 96% ee in CHCl~3~ at room temperature for 3 h (Table [1](#Tab1){ref-type="table"}, entry 1). For the purpose of improving the *E/Z* selectivity, we tried to identify a more stereoselective catalyst. Based on our recent development of monophosphine ligands^[@CR44]^, some of the gold complexes of these ligands have been prepared. AuCl(LB-Phos), the structure of which was determined by X-ray single crystal diffraction study (Fig. [3](#Fig3){ref-type="fig"})^[@CR45]^, is one of them.Fig. 3Complex AuCl(LB-Phos). Synthesis and ORTEP representation of AuCl(LB-Phos)

Optimization of reaction conditions {#Sec4}
-----------------------------------

With this rather sterically bulky AuCl(LB-Phos), gladly, an *E*/*Z* selectivity of 97:3 with 100% yield and 97% ee was observed, indicating that the new catalyst was able to control both the C=C stereoselectivity and ensure the efficiency of chirality transfer (Table [1](#Tab1){ref-type="table"}, entry 2). Inspired by this result, we explored the effect of solvents: CH~2~Cl~2~ gave a similar *E*/*Z* and ee (Table [1](#Tab1){ref-type="table"}, entry 3), while 1,2-DCE led to a rather poor *E*/*Z* selectivity of 91:9 (Table [1](#Tab1){ref-type="table"}, entry 4); CH~3~NO~2~ showed a better *E*-selectivity of 98:2, but a much lower ee of 90% (Table [1](#Tab1){ref-type="table"}, entry 6); other solvents such as toluene, dioxane, and CH~3~CN failed to yield any better results even with a prolonged time of 12 h (Table [1](#Tab1){ref-type="table"}, entries 5, 7--8). In the absence of AgOTs, the expected product **6a** was obtained in only 8% yield with 92% recovery of (*R*~a~)-**5a** after 24 h (Table [1](#Tab1){ref-type="table"}, entry 9), and the lactonization couldn't take place by just using AgOTs (Table [1](#Tab1){ref-type="table"}, entry 10), indicating the significance of the gold-catalysis. Examining the effect of different salts showed the importance of the counter anion: AgPF~6~ resulted in the same *E/Z*-selectivity but with a lower ee of 92% (Table [1](#Tab1){ref-type="table"}, entry 11), while other common silver salts such as AgOTf, AgSbF~6~, and AgOAc, etc. all caused a dropped *E*/*Z* selectivity ranging from 82:18 to 93:7 (Table [1](#Tab1){ref-type="table"}, entries 12--16). Thus, we defined the standard reaction conditions as follows: 5 mol% Au(LB-Phos)Cl/AgOTs in CHCl~3~ at 25 °C for 3 h (Table [1](#Tab1){ref-type="table"}, entry 2).Table 1Optimization of the reaction conditions for AuCl(LB-Phos)-catalyzed stereoselective cyclization of 4,5-allenoic acid (*R*~a~)-**5a**![](41467_2018_3894_Figc_HTML.gif){#d29e715}Entry\[Ag\]solvent*t* (h)6a^a^ee^b^ of (*S*,*E*)-6a (%)Yield (%)(*S*,*E*)*/*(*R*,*Z*)1^c,d^AgOTsCHCl~3~410093:7962^d^AgOTsCHCl~3~310097:3973AgOTsCH~2~Cl~2~310096:4954AgOTs1,2-DCE^e^39891:9965AgOTstoluene1210094:6956AgOTsCH~3~NO~2~39998:2907AgOTsdioxane1210094:6968AgOTsCH~3~CN1210097:3959^f^--CHCl~3~248----10^g^AgOTsCHCl~3~240----11AgPF~6~CHCl~3~310097:39212AgOMsCHCl~3~129993:79713AgOTfCHCl~3~210092:8--14AgSbF~6~CHCl~3~29691:9--15AgOAcCHCl~3~8.510082:18--16AgBF~4~CHCl~3~29992:8--AgOTs (0.01 mmol), AuCl(LB-Phos) (0.01 mmol), and solvent (2 mL) were stirred at room temperature for 15 min under nitrogen atmosphere; then 0.2 mmol (*R*~a~)-**5a** and solvent (1 mL) were added^a^ Determined by ^1^H NMR of the crude product using 1,3,5-trimethylbenzene as internal standard^b^ Determined by chiral high-performance liquid chromatography (HPLC) analysis^c^ 2.5 mol% Au~2~Cl~2~(dppm) was used instead of AuCl(LB-Phos)^d^ The reaction was conducted at 25 °C^e^ 1,2-DCE: 1,2-dichloroethane^f^ 92% recovery of (*R*~a~)-**5a**^g^ The reaction was conducted in the absence of AuCl(LB-Phos); 100% recovery of (*R*~a~)-**5a**

Substrate scope {#Sec5}
---------------

With the optimized reaction conditions in hand, differently substituted 4,5-allenoic acids (*R*~a~)-**5** were treated with AuCl(LB-Phos) to afford γ-1*(E)*-*alkenyl* (*S*)-γ-butyrolactones in high yields (93--98%) with an excellent axial-to-center chirality transfer and *E*/*Z*-selectivity (up to \>99:1 *E*/*Z*) (Table [2](#Tab2){ref-type="table"}): R could be primary alkyl: *n*-heptyl (**6a**), *n*-butyl (**6b**), *n*-undecyl (**6c**), and phenylethyl (**6g**), or branched alkyl: *i*-Pr (**6d**), and Cy (**6e**). The reaction of benzyl-substituted (*R*~a~)-**5f** should be conducted at −40 °C for 6 h to keep the enantioselectivity due to the observed racemization at 25 °C (**6f**) (compare entry 6 with entry 7 in Table [2](#Tab2){ref-type="table"}). Functional groups including benzyl group, C=C, and C≡C bonds were also tolerated (**6f**, **6g**, **6h**, and **6i**).Table 2Highly stereoselective synthesis of (*S*, *E*)-**6**![](41467_2018_3894_Figd_HTML.gif){#d29e1367}Entry(*R*~a~)-5(*S*,*E*)-6Ree (%)Yield^a^ (%)(*S,E*)*/*(*R*,*Z*)^b^ee^c^ (%)1*n*-C~7~H~15~ ((*R*~a~)-**5a**)9696 (**6a**)98:2 (97:3)962*n*-C~4~H~9~ ((*R*~a~)-**5b**)9793 (**6b**)97:3 (96:4)963^d^*n*-C~11~H~23~ ((*R*~a~)-**5c**)9798 (**6c**)98:2 (97:3)964*i*-Pr ((*R*~a~)-**5d**)9894 (**6d**)99:1^e^985Cy ((*R*~a~)-**5e**)9796 (**6e**)99:1^e^966Bn ((*R*~a~)-**5f**)9690 (**6f**)95:5 (95:5)857^f^Bn ((*R*~a~)-**5f**)9695 (**6f**)98:2 (97:3)978BnCH~2~ ((*R*~a~)-**5g**)9697 (**6g**)97:3 (95:5)979^g^CH~2~=CH(CH~2~)~8~ ((*R*~a~)-**5h**)9694 (**6h**)\>99:1 (97:3)9610TBSC≡C(CH~2~)~6~ ((*R*~a~)-**5i**)9796 (**6i**)97:3 (97:3)97AgOTs (0.05 mmol), AuCl(LB-Phos) (0.05 mmol), and CHCl~3~ (5 mL) were stirred at room temperature for 15 min under nitrogen atmosphere; then 1.0 mmol (*R*~a~)-**5** and CHCl~3~ (5 mL) were added at 25 °C^a^ Isolated yield^b^ Determined by ^1^H NMR of the isolated product; the data in parentheses were determined by ^1^H NMR of crude product using 1,3,5-trimethylbenzene as internal standard^c^ Determined by chiral HPLC analysis of isolated (*S*, *E*)-**6**^d^ Reaction time was 2.5 h^e^ Not able to be determined in the crude product; determined by quantitative ^13^C NMR of the isolated product^f^ The reaction was conducted at −40 °C for 6 h^g^ The reaction time was 2 h

As expected, the enantiomer (*R*,*E*)-butyrolactone (**6j**) could also be prepared from the enantiomer of the starting allene, (*S*~a~)-4,5-dienoic acid (*S*~a~)-**5j**, in a high yield and an excellent *E*/*Z*-selectivity (Fig. [4a](#Fig4){ref-type="fig"}). After some further optimization (see Supplementary Table [3](#MOESM1){ref-type="media"}), a 10 mmol scale reaction with just 1.5 mol% each of AuCl(LB-Phos) and AgOTs in CHCl~3~ at −20 °C for 15 h was realized, delivering an excellent yield of chiral lactone (*S*,*E*)-**6b** with 97% ee and 98:2 *E*/*Z* selectivity (Fig. [4b](#Fig4){ref-type="fig"}).Fig. 4Extended scope of Au-catalyzed cycloisomerization reaction. **a** Synthesis of the enantiomer (*R*,*E*)-butyrolactone **6j**; **b** Gram scale synthesis for γ-butyrolactone (*S*, *E*)-**6b**

The effect of different gold catalysts {#Sec6}
--------------------------------------

The results of different gold catalysts combined with AgOTs in CHCl~3~ are listed in Table [3](#Tab3){ref-type="table"}, which showed that AuCl(LB-Phos) was indeed the best catalyst (Table [3](#Tab3){ref-type="table"}, entry 6).Table 3The effect of different gold catalyst on the stereoselective cyclization of 4,5-allenoic acid (*S*~a~)-**5m**![](41467_2018_3894_Figa_HTML.gif){#d29e1977}![](41467_2018_3894_Figb_HTML.gif){#d29e1984}Entry\[Au\]6mee of (*S*,*E*)-6m (%)^b^Yield^a^(*R*,*E*)/(*S*,*Z*)^a^1^c^AuCl11----2AuCl(IPr)10095:5963^d^Au~2~Cl~2~(dppm)9993:7994AuCl(*t*-Bu~3~P)9896.5:3.5975AuCl(Ph~3~P)9894:6996AuCl(LB-Phos)10097:3997^e^AuCl(Zheda-Phos)9996:4998^f^AuCl(Gorlos-Phos)9394:692AgOTs (0.01 mmol), \[Au\] (0.01 mmol), and CHCl~3~ (2 mL) were stirred at room temperature for 15 min under nitrogen atmosphere; then 0.2 mmol of (*S*~a~)-**5m** and CHCl~3~ (1 mL) were added; the reaction mixture was then continuously stirred at 25 °C for 4 h^a^ Determined by ^1^H NMR of crude product using 1,3,5-trimethylbenzene as internal standard^b^ Determined by chiral high-performance liquid chromatography (HPLC) analysis^c^ The reaction was conducted in the absence of AgOTs; 88% of (*S*~a~)-**5m** was recovered^d^ 2.5 mol% Au~2~Cl~2~(dppm) was used^e^ Reaction time was 3.75 h^f^ 2% recovery of (*S*~a~)-**5m**

Synthesis of racemic xestospongiene {#Sec7}
-----------------------------------

Such a strategy should deliver a direct entry to the optically active natural γ-butyrolactone with common structure *E*-**I** as shown in Fig. [1a](#Fig1){ref-type="fig"}. Xestospongienes are a series of brominated polyunsaturated lipids isolated from the Chinese marine sponge *Xestospongia testudinaria* (shown in Fig. [1a](#Fig1){ref-type="fig"})^[@CR4]^. No total synthesis has been reported yet. Thus, 7-((*tert*-butyldimethylsilyl)oxy)heptanal **7** underwent 1,2-addition reaction with ethyl magnesium bromide to yield propargylic alcohol **8**. Methylation of **8** via deprotonation with NaH, followed by quenching with MeI, and subsequent removal of the TBS group via acidic hydrolysis yielded the primary alcohol **9** with a terminal C-C triple bond in 88% yield. Fe(III)-catalyzed aerobic oxidation of **9** afforded aldehyde **10** in 62% yield^[@CR46]^. Wittig olefination of the aldehyde functionality in **10** afforded the terminal alkyne **1c**^[@CR47]^, which underwent the ATA (allenylation of terminal alkynes) reaction with methyl 4-oxobutanoate **2k** (readily available from γ-butyrolactone in 2 steps^[@CR48]^) in the presence of diphenylprolinol *rac*-**3a** in a sealed tube at 130 °C^[@CR49]^ to yield 4,5-allenoate *rac*-**4ck** in 64% yield. Through hydrolysis, allenoic acid *rac*-**5k** was prepared in 96% yield with a d.r. of 1.07:1, which underwent the gold-catalyzed cycloisomerization with 10 mol% catalyst at −30 °C for 24 h (for details, see Supplementary Table [4](#MOESM1){ref-type="media"}) to afford *rac*-xestospongiene in an excellent yield and *E*/*Z* ratio of 99:1 (Fig. [5](#Fig5){ref-type="fig"}).Fig. 5First total synthesis of *rac*-xestospongiene. Reagents and conditions: i. ethynyl-magnesium bromide (1.7 equiv.), THF, rt, 12.5 h; ii. NaH (1.0 equiv.), THF, 0 °C, 0.5 h, then rt, 0.5 h; then MeI (1.2 equiv.), 0 °C, 2 min, then rt, 5 h; then HCl (aq., 3.0 M), 0 °C, then rt, 1.5 h; iii. Fe(NO~3~)~3~∙9H~2~O (8 mol%), TEMPO (8 mol%), NaCl (8 mol%), O~2~ balloon, DCM, 25 °C, 12.5 h; iv. CBr~4~ (1.5 equiv.), PPh~3~ (3.0 equiv.), DCM, 0 °C, 0.5 h, then 0 °C \~ rt, 1 h; v. *rac*-**3a** (1.5 equiv.), methyl 4-oxobutanoate **2k** (1.5 equiv.), CuBr~2~ (20 mol%), dioxane, 130 °C, 17 h; vi. LiOH∙H~2~O (1.5 equiv.), EtOH/H~2~O = 1:1, 90 °C, 1.5 h; vii. AuCl(LB-Phos) (10 mol%), AgOTs (10 mol%), CHCl~3~, -30 °C, 24 h

Asymmetric synthesis of xestospongienes E--H {#Sec8}
--------------------------------------------

It is well known that different stereoisomers of drug molecules may show very distinct biological activities. After methylation, deprotection, aerobic oxidation, and Wittig olefination reaction, (*R*)-**8** and (*S*)-**8** (for their syntheses, see Supplementary Tables [5](#MOESM1){ref-type="media"}, [6](#MOESM1){ref-type="media"} and Supplementary Methods^[@CR50]^) were easily converted to terminal propargylic methyl ethers (*R*)-**1c** and (*S*)-**1c**, respectively (Fig. [6a, b](#Fig6){ref-type="fig"}).Fig. 6First total synthesis of xestospongienes E--H. **a** Synthesis of (*R*)-**1c**; **b** Synthesis of (*S*)-**1c**; **c** Total synthesis of xestospongiene F; **d** Total synthesis of xestospongiene G; **e** Total synthesis of xestospongiene H; **f** Total synthesis of xestospongiene E. Reagents and conditions: i. NaH (1.0 equiv.), THF, 0 °C then rt; then MeI (1.2 equiv.), 0 °C \~rt; then HCl (aq., 3.0 M), MeOH, rt; ii. Fe(NO~3~)~3~∙9H~2~O (10 mol%), TEMPO (10 mol%), NaCl (10 mol%), O~2~ balloon, DCM, rt; iii. CBr~4~ (1.5 equiv.), PPh~3~ (3.0 equiv.), DCM, 0 °C; iv. methyl 4-oxobutanoate **2k** (1.5--1.7 equiv.), CuBr~2~ (20 mol%), dioxane, 120 °C; v. LiOH∙H~2~O (1.5 equiv.), EtOH/H~2~O = 1:1, 90 °C; vi. AuCl(LB-Phos) (10 mol%), AgOTs (10 mol%), CHCl~3~, −30 °C

The reaction of (*R*)-**1c**, **2k**, and (*S*)-diphenylprolinol (*S*)-**3a** in a ratio of 1:1.5:1.5 afforded (*R*~a~,*R*)-**4ck** as a single stereoisomer in 47% yield with \>99% ee and \>99:1 d.r. Hydrolysis of (*R*~a~,*R*)-**4ck** was conducted subsequently by its treatment with LiOH∙H~2~O at 90 °C for 1.5 h affording (*R*~a~,*R*)-**5k**, which was cycloisomerized with 10 mol% of AuCl(LB-Phos) at −30 °C to afford (5 *S*,1′*E*,3′*R*)-**6k**, i.e., xestospongiene F (reported as xestospongiene E^[@CR4]^) in 94% yield with \>99% ee and \>99:1 d.r (Fig. [6c](#Fig6){ref-type="fig"}). Xestospongienes G, H, and (5 *R*,1′*E*,3′*S*)-**6k**, i.e., xestospongiene E (reported as Xestospongiene F^[@CR4]^) could also be obtained easily with high stereo- and enantioselectivity in a similar way by just replacing amino alcohol (*S*)-**3a** with (*R*)-**3a** or propargylic alcohol (*R*)-**1c** with (*S*)-**1c** (Fig. [6d--f](#Fig6){ref-type="fig"}). Subsequently, gram scale synthesis of xestospongiene F was easily realized with a high enantiopurity (99% ee and 98:2 d.r.) (for details, see Supplementary Methods).

Asymmetric syntheses of naturally occurring γ-alkylic γ-lactones {#Sec9}
----------------------------------------------------------------

As stated above, aliphatic γ-butyrolactones are the major aroma components of many industrial fragrances and ingredients in flavors and as food additives^[@CR11]^, some of which also work as quorum-sensing molecules in vivo^[@CR51]^. Hydrogenation of the C=C bond in (*E*)-alkenyl γ-butyrolactones *E*-**I** would provide an efficient entry to these naturally occurring γ-alkylic γ-lactones **II** listed in Fig. [1b](#Fig1){ref-type="fig"}, provided that the cleavage of the allylic C--O bond causing racemization to the chiral center under the transition metal catalysis may be avoided.

It has been established that the two enantiomers of γ-alkylic γ-butyrolactones made some differences in odor quality and odor intensity^[@CR11],[@CR52],[@CR53]^. Thus, we tried to synthesize both (*R*) and (*S*)-γ-lactones by utilizing the current strategy. Starting from asymmetric allenylation of readily available ethyl pent-4-ynoate **1b** with nonanal **2j** in the presence of (*S*)-**3a**, followed by hydrolysis, 4,5-allenoic acid (*R*~a~)-**5j** was afforded in 39% yield with 95% ee. Subsequent Au-catalyzed cycloisomerization of (*R*~a~)-**5j** was executed to yield γ-butyrolactone bearing a *trans* C=C bond (*S*,*E*)-**6j** in 96% yield with 96% ee and 97:3 *E*/*Z*. (*R*)-4-tetradecalactone was obtained by hydrogenation of (*S*,*E*)-**6j** in the presence of 5 mol% Pd/C in 98% yield with 93% ee (Fig. [7a](#Fig7){ref-type="fig"})^[@CR30],[@CR31],[@CR54],[@CR55]^.Fig. 7Synthesis of biologically active aliphatic γ-butyrolactones. **a** Synthesis of biologically active (*R*)-4-tetradecalactone; **b** Synthesis of biologically active (*S*)-4-tetradecalactone; **c** Synthesis of biologically active (*R*)-γ-palmitolactone; **d** Synthesis of biologically active (*R*)-4-decalactone. Reagents and conditions: i. ethyl pent-4-ynoate **1b** (1.2 equiv.), **2** (1.5 equiv.), **3** (1.0 equiv.), CuBr~2~ (20 mol%), dioxane, 120 °C; ii. LiOH∙H~2~O (1.5 equiv.), EtOH/H~2~O = 1:1, 90 °C; iii. AuCl(LB-Phos)/AgOTs (1.5--5 mol%), CHCl~3~; iv. Pd/C (2.4--5 mol%), H~2~ (25 atm), EtOAc, rt

The enantiomer (*S*)-4-tetradecalactone was executed by following the same synthetic route just by replacing (*S*)-**3a** with (*R*)-**3a** in the step of EATA (enantioselectivi allenylation of terminal alkynes) reaction, giving the desired product with a similar yield and enantioselectivity (Fig. [7b](#Fig7){ref-type="fig"})^[@CR30],[@CR55]^. Similarly, naturally occurring aromatic (*R*)-γ-palmitolactone was synthesized in 96% ee by just using undecanal **2l** as the starting aldehyde in EATA reaction (Fig. [7c](#Fig7){ref-type="fig"})^[@CR56]^. (*R*)-4-Decalactone is a sex pheromone of *Osmoderma eremite* released mainly or exclusively by male beetles^[@CR57]^, which has also proven to be cytotoxic^[@CR58],[@CR59]^, and synthesized with biocatalysts^[@CR26],[@CR58],[@CR59]^ or by other strategies^[@CR29],[@CR53],[@CR60]^. Gram scale synthesis of (*R*)-4-decalactone was also realized easily in 43% total yield for 4 steps with 94% ee (Fig. [7d](#Fig7){ref-type="fig"}).

Discussion {#Sec10}
==========

A facile strategy for general asymmetric synthesis of two types of common γ-butyrolactones from readily available common chemicals-terminal alkynes and aldehydes-has been developed by applying the newly identified catalyst, AuCl(LB-Phos), with the stereoselectivity of up to \>99:1 *E*/*Z* and \>99% ee. The first total syntheses of xestospongienes E, F, G, and H have been realized with high stereoselectivity. In addition, the C--O bond cleavage-free hydrogenation led to a general access to naturally occurring γ-alkyl γ-butyrolactones, such as (*R*)-4-tetradecalactone, (*S*)-4-tetradecalactone, (*R*)-γ-palmitolactone, and (*R*)-4-decalactone, efficiently with ee of 93--96%. Such a modular solution to two different types of optically active γ-butyrolactones will surely stimulate further interest in the synthetic and bio-potential of these compounds and identifying even better aromas for human life. Further studies on this area are being carried out in our laboratory.

Methods {#Sec11}
=======

General method for cycloisomerization of alkadienoic acids {#Sec12}
----------------------------------------------------------

To a dry Schlenk tube were added AgOTs (0.0142 g, 0.05 mmol, weighed in glove box, 98%), AuCl(LB-Phos) (0.0299 g, 0.05 mmol), and CHCl~3~ (5 mL) under nitrogen atmosphere sequentially. After stirring for 15 min, (*R*)-trideca-4,5-allenoic acid (*R*~a~)-**5a** (0.2108 g, 1 mmol) and CHCl~3~ (5 mL) were added. After being continuously stirred at 25 °C for 3 h, the reaction was complete as monitored by thin layer chromatography (TLC). Filtration through a short column of silica gel \[eluent: Et~2~O (20 mL × 3)\] and evaporation afforded a crude mixture of (*S*,*E*)-**6a** and (*R*,*Z*)-**6a** ((*S*,*E*)*/*(*R*,*Z*) = 97:3, as determined by ^1^H NMR analysis). Column chromatography on silica gel afforded (*S*,*E*)-**6a** (0.2017 g, 96%, (*S*,*E*)*/*(*R*,*Z*) = 98:2 as determined by ^1^H NMR analysis) \[eluent: petroleum ether (60--90 °C)/ethyl acetate = 15/1 (400 mL) to 10/1 (550 mL)\] as an oil with pleasant flavor: 96% ee (HPLC conditions: Chiralcel OJ-H column, *n*-hexane/*i*-PrOH = 200/1, 1.0 mL/min, *λ* = 214 nm, *t*~R~ (major) = 22.73 min, *t*~R~ (minor) = 20.86 min); \[*α*\]~D~^20^ = + 29.6 (*c* = 1.01, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) *δ* 5.81 (dt, *J*~1~ = 15.3 Hz, *J*~2~ = 7.2 Hz, 1H, =CH), 5.49 (dd, *J*~1~ = 15.3 Hz, *J*~2~ = 7.2 Hz, 1H, =CH), 4.90 (q, *J* = 7.2 Hz, 1H, CH), 2.61--2.50 (m, 2H, CH~2~), 2.46--2.31 (m, 1H, one proton from CH~2~), 2.13--1.90 (m, 3H, CH~2+~ one proton from CH~2~), 1.45--1.18 (m, 10H, CH~2~ × 5), 0.88 (t, *J* = 6.6 Hz, 3H, CH~3~); the following signals are discernible for (*R*,*Z*)-**6a**: *δ* 5.72--5.62 (m, 1H, =CH), 5.31--5.21 (m, 1H, CH); ^13^C NMR (75 MHz, CDCl~3~) *δ* 177.0, 135.6, 127.2, 81.1, 32.0, 31.6, 29.0, 28.9, 28.7, 28.64, 28.61, 22.5, 14.0; IR (neat) *ν* (cm^−1^) 2955, 2926, 2855, 1778, 1673, 1459, 1415, 1378, 1327, 1296, 1216, 1177, 1123, 1010; GC-MS (GC condition: injector: 280 °C; column: DB5 column 30 m × 0.25 mm, temperature programming: 60 °C (2 min), 20 °C/min to 280 °C, 280 °C (30 min); detector: 280 °C) (70 ev, EI) *m/z* (%) for (*S*,*E*)-**6a**: *t*~R~ (major) = 5.83 min: 210 (M^+^, 2.31), 111 (100); for (*R*,*Z*)-**6a**: *t*~R~ (minor) = 5.76 min: 210 (M^+^, 0.75), 111 (100). HRMS calcd for C~13~H~22~O~2~ \[M^+^\]: 210.1620, found: 210.1624.
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